Law and regulation

Salters Cartage owner cries poor while nobbling rivals. By Victoria Young

See details.

AFT posts loss that meets estimates in maiden result as Australian sales overtake NZ

Pattrick Smellie
Tue, 24 May 2016

By Pattrick Smellie May 25 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based drug developer, posted a $8.9 million operating loss for the year to March 31, its first result since listing on the NZX and ASX last December, and in line with analyst expectations. Total revenue rose 14 percent to $64 million, in part reflecting ongoing fast sales growth in the Australian market of its flagship ibuprofen-paracetamol painkiller, Maxigesic. Australian sales rose 19 percent to $31.2 million while New Zealand revenue rose 5.8 percent to $31....

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Technology
Shift72 profitable after 740% covid growth
Henry Burrell | Mon, 30 Nov 2020

Chief executive of the Kiwi video streaming software company explains how he’s quadrupled his workforce to serve the global film festival market.

Primary Sector
Flying kiwi hitting export returns
Rebecca Howard | Mon, 30 Nov 2020

The kiwi dollar is more than 15 cents higher than the covid low.

Opinion
Where can you put your money at present?
Brian Gaynor | Sat, 28 Nov 2020

In a low interest rate environment and with residential property running hot, where does today's investor look for other sources of blue sky?

Sponsored
Looking to future-proof your business management skills?

Job candidates who have the knowledge and skills to manage strategy, data and communications in an agile fashion will undoubtedly have a competitive advantage.

Sponsored
CFDs: An alternative to traditional stockmarket investing

One of the unusual side-effects of the financial crisis caused by the covid-19 pandemic has been the explosion in online investment trading.